Outpatient parenteral antimicrobial therapy for infective endocarditis: A cost-effective strategy

Medecine et Maladies Infectieuses

Volumn 44, Issue 7, 2014, Pages 327-330

  Lacroix, A ^a   Revest, M ^a,b   Patrat Delon, S ^a   Lemaitre F ^a,b   Donal, E ^a   Lorleac'h A ^a   Arvieux, C ^a   Michelet, C ^a,b   Tattevin, P ^a,b,c  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Cost effectiveness; Infective endocarditis; Outpatient parenteral antimicrobial therapy

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; CEFTRIAXONE; DAPTOMYCIN; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HOSPITAL COST; HUMAN; LENGTH OF STAY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; VERY ELDERLY; AMBULATORY CARE; CENTRAL VENOUS CATHETER; COST OF ILLNESS; ECONOMICS; ENDOCARDITIS; FRANCE; HOME CARE; HOSPITALIZATION; INFUSION PUMP; INJECTION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; STATISTICS AND NUMERICAL DATA; TRAFFIC AND TRANSPORT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; CENTRAL VENOUS CATHETERS; COMBINED MODALITY THERAPY; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG COSTS; ENDOCARDITIS; FEMALE; FRANCE; HOME CARE SERVICES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; INJECTIONS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TRANSPORTATION; YOUNG ADULT;

EID: 84905036870     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2014.05.001     Document Type: Article

References (17)

1. Chapman A.L.N., Dixon S., Andrews D., et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009, 64:1316-1324.
2. Habib G., et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 2009, 30:2369-2413.
3. Stamboulian D. Outpatient treatment of endocarditis in a clinic-based program in Argentina. Eur J Clin Microbiol Infect Dis 1995, 14:648-654.
4. Larioza J., Heung L., Girard A., Brown R.B. Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy. South Med J 2009, 102(6):575-579.
5. Huminer D., Bishara J., Pitlik S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999, 18(5):330-334.
6. Kate Gould F., David W., Denning, Tom S.J., Elliott, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012, 67:269-289.
7. Amodeo M.R., Clulow T., Lainchbury J., et al. Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect 2009, 59:387-393.
8. Huminer D., Bishara J., Pitlik S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999, 18:330-334.
9. Seaton R.A., Barr D.A. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Int Med 2013, 24:617-623.
10. Andrews M.-M., von Reyn C.F. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001, 33:203-209.
11. Alan D.T., Susan R.J., Dalovisio J.R., et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004, 38:1651-1672.
12. Duncan A.C.J, Barr A.D., Seaton R.A. OPAT outcomes in endocarditis. BMJ 2013, 346:f2484.
13. Christopher J.A., Duncan D.A., Antonia Ho1 B., et al. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. J Antimicrob Chemother 2013, 68:1650-1654.
14. McMahon J.H., O'keeffe J.M., Victorian H., Grayson M.L. Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?. Scand J Infect Dis 2008, 40(1):40-43. Outcomes Study Group.
15. Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and, Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version, 2009). Eur Heart J 2009, 30:2369-2413.
16. Cervera C., del Río A., García L., et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin 2011, 29(8):587-592.
17. Partridge D.G., O'Brien E.A.L., Chapman N. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years'experience at a UK centre. Postgrad Med J 2012, 88:377-381.